Alimera sciences appoints todd wood as president of u.s. operations and reports inducement grant under nasdaq listing rule 5635(c)(4)

Atlanta, dec. 12, 2023 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera” or the “company”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better vision longer, today announced the appointment of todd wood as president u.s. effective immediately.
ALIM Ratings Summary
ALIM Quant Ranking